Low-dose cyclosporin A therapy in cadaver renal transplantation in children. 1989

H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
Division of Pediatric Nephrology, University Hospital, Heidelberg, Federal Republic of Germany.

Fifty-one pediatric patients undergoing a first cadaveric kidney transplantation were followed for at least 2 years after grafting. They were divided into two groups: those treated with methylprednisolone plus azathioprine (AZA) and those treated with methylprednisolone plus low-dose cyclosporin A (CyA; median dose 109 mg/m2 per day = 3.4 mg/kg per day after 1 year). The steroid dosage given was significantly lower in the second group. The 4-year graft survival rate was 68% for the AZA group and 78% for the CyA group. Renal function did not differ significantly in the two groups; after 1, 2, and 3 years, the median 24-h creatinine clearance was 79, 69, and 51 ml/min/1.73 m2, respectively, for the AZA group and 78, 63, and 68 ml/min/1.73 m2, respectively, for the CyA group. Linear growth was similar in the two groups. We conclude that in pediatric patients the results of low-dose CyA immunosuppression do not differ significantly from those obtained with AZA in terms of graft survival, renal function, or growth.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
February 1989, Transplantation proceedings,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
January 1986, The International journal of pediatric nephrology,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
December 1972, Transplantation proceedings,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
March 1977, Transplantation proceedings,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
August 1985, The Ulster medical journal,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
January 1988, The British journal of surgery,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
September 1984, Lancet (London, England),
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
January 1999, Journal of pediatric hematology/oncology,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
October 1977, The American journal of medicine,
H Ruder, and J Strehlau, and F Schaefer, and N Gretz, and D E Müller-Wiefel, and K E Bonzel, and K Möhring, and S Pomer, and O Mehls, and K Schärer
February 1987, Transplantation proceedings,
Copied contents to your clipboard!